Everolimus Mylan 10 mg tablete
| Name | Everolimus Mylan 10 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-172686253 |
| Active Substance | everolimus |
| Composition | jedna tableta sadrži 10 mg everolimusa |
| Pharmaceutical Form | tableta |
| Packaging [MA Number for Packaging] | 30 tableta u blisteru, u kutiji [HR-H-172686253-01] 30 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-172686253-02] 90 tableta u blisteru, u kutiji [HR-H-172686253-03] |
| Manufacturer | Synthon Hispania S.L., Barcelona, Španjolska
Synthon BV, Nijmegen, Nizozemska |
| Marketing Authorisation Holder | Mylan Pharmaceuticals Limited, Damastown Industrial Park, Mulhuddart, Dublin, Irska |
| Marketing Authorisation Date | 24.02.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/136 |
| Registration Number | 381-12-01/38-23-03 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01EG02 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
